L-valine ester of cyclopropavir: A new antiviral prodrug

Antiviral Chemistry and Chemotherapy

Volumn 20, Issue 1, 2009, Pages 37-46

  Wu, Zhimeng ^a   Drach, John C ^b   Prichard, Mark N ^c   Yanachkova, Milka ^d   Yanachkova, Ivan ^d   Bowlin, Terry L ^e   Zemlicka, Jiri ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d GLSYNTHESIS INC   (United States)

^e MICROBIOTIX INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYCLOPROPAVIR; GANCICLOVIR; PRODRUG; UNCLASSIFIED DRUG; VALACICLOVIR; VALCYCLOPROPAVIR; VALGANCICLOVIR;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; CYCLOPROPANES; CYTOMEGALOVIRUS; ESTERS; GANCICLOVIR; GUANINE; HUMANS; HYDROLYSIS; MICE; PRODRUGS; VALINE; VIRUS REPLICATION;

EID: 70350341964     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP782     Document Type: Article

References (18)

1. Mackman R, Cihlar T. Prodrug strategies in the design of nucleoside and nucleotide antiviral therapeutics. Annu Rep Med Chem 2004; 39:305-321.
2. Beauchamp LM, Orr GF, de Miranda P, Burnette T, Krenitsky TA. Amino acid ester prodrugs of acyclovir. Antivir Chem Chemother 1992; 3:157-164.
3. Perry CM, Faulds D. Valaciclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs 1996; 52:754-772.
4. Ormrod D, Scott LJ, Perry CM. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections. Drugs 2000; 59:839-863.
5. Nestor JJ, Womble SW, Maag H, inventors; Syntex (USA) Inc., assignee. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative. United States Patent 6083953. 4 July, 2000.
6. Curran M, Noble S. Valganciclovir. Drugs 2001; 61:1145-1150.
7. Ganapathy ME, Huang W, Wang H, Ganapathy V, Leibach FH. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun 1998; 246:470-475.
8. Kim I, Song X, Vig BS, et al. A novel nucleoside prodrug-activating enzyme: Substrate specificity of biphenyl hydrolase-like protein. Mol Pharm 2004; 1:117-127.
9. Bryant ML, Bridges EG, Placidi L, et al. Antiviral l-nucleosides specific for hepatitis B virus infection. Antimicrob Agents Chemother 2001; 45:229-235.
10. Bichko V, Tausek M, Qiu L, et al. Enhanced antiviral activity of NM 107, alone or in combination with interferon γ J Hepatol 2005; 42 Suppl 2:154.
11. Gosselin G, Pierra C, Benzaria S, et al. β-L-2′-Deoxythymidine (LdT) and β-L-2′-deoxycytidine (LdC): how simple structures can be potent, selective and specific anti-HBV drugs. In Schinazi RF, Liotta DC (Editors). Frontiers in nucleosides and nucleic acids. Tucker, GA: IHL Press 2005; pp. 309-317.
12. Pierra C, Amador A, Benzaria S, et al. Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2′-C-methylcytidine. J Med Chem 2006; 49:6614-6620.
13. Zemlicka J. Methylenecyclopropane analogues of nucleosides as anti-herpes agents. In E De Clercq (Editor). Advances in antiviral drug design. Amsterdam: Elsevier 2007; pp. 113-165.
14. Zhou S, Breitenbach JM, Borysko KZ, et al. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl) cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides. J Med Chem 2004; 47:566-575.
15. Kern ER, Kushner NL, Hartline CB, et al. In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication. Antimicrob Agents Chemother 2005; 49:1039-1045.
16. Kern ER, Bidanset DJ, Hartline CB, Yan Z, Zemlicka J, Quenelle DC. Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections. Antimicrob Agents Chemother 2004; 48:4745-4753.
17. Yan Z, Kern ER, Gullen E, Cheng YC, Drach JC, Zemlicka J. Nucleotides and pronucleotides of 2,2-bis(hydroxymethyl)methylenecyclopropane analogues of purine nucleosides: synthesis and antiviral activity. J Med Chem 2005; 4891-99.
18. Stefanidis D, Brandl M. Reactivity of valganciclovir in aqueous solution. Drug Dev Ind Pharm 2005; 31:879-884.